Minit Shah

7PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Apr 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial.

|Jan 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Vanita Noronha, Vijay Patil, Nandini Menon

|Dec 31, 2025
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India.

Atul Tiwari, Ajay Kumar Singh, Vanita Noronha

|Jul 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in THRA, a Potential Modifier of Cellular Plasticity.

Vaishakhi Trivedi, Vanita Noronha, Munita Bal

|May 05, 2025
Comprehensive Genomic Profiling of Indian Patients With Lung Cancer.

Shivani Sharma, Vanita Noronha, Arti Yadav

Pageof 2

Frequent Collaborators

6 joint publications

Vanita Noronha

6 joint publications

Nandini Menon

5 joint publications

Kumar Prabhash

3 joint publications

Vijay Patil